can you build muscle while on glp-1 Do medications cause loss? Glucagon-like peptide-1 receptor agonists and

Marston, Eastern District of Pennsylvania Number of Cases: Approximately 2,947 pending cases (and growing rapidly) Defendants: Novo Nordisk and Eli Lilly Covered Drugs: Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Victoza, Saxenda, Trulicity Key Developments: August 15, 2025 - Landmark Ruling: Judge Marston ruled that gastroparesis claims require objective diagnostic testing (gastric emptying scan)

Its structure comprises seven standardized files: demographic data (DEMO), medication records (DRUG), AE descriptions (REAC), patient outcomes (OUTC), reporter information (RPSR), drug therapy timelines (THER), and treatment indications (INDI) 14,18,19

Long-term administration of (Pro 3 )GIP to obese mice on an HFD was found to reduce body weight by about 8% compared to controls, without affecting food intake, and decrease casual blood glucose levels during the course of treatment and attenuated insulin levels during an oral glucose tolerance test [118]

The FDA approved oral semaglutide 25 mg, also known as the Wegovy pill, making it the first GLP-1 tablet approved specifically for obesity

Access the complete GLP-1 Pipeline Update table for November 2025